title: Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.
abstract: Neuroendocrine (NE) phenotype, seen in >30% of prostate adenocarcinomas (PCa), and NE prostate tumors are implicated in aggressive prostate cancer. Formation of NE prostate tumors in the TRAMP mouse model was suppressed in mice lacking the ubiquitin ligase Siah2, which regulates HIF-1alpha availability. Cooperation between HIF-1alpha and FoxA2, a transcription factor expressed in NE tissue, promotes recruitment of p300 to transactivate select HIF-regulated genes, Hes6, Sox9, and Jmjd1a. These HIF-regulated genes are highly expressed in metastatic PCa and required for hypoxia-mediated NE phenotype, metastasis in PCa, and the formation of NE tumors. Tissue-specific expression of FoxA2 combined with Siah2-dependent HIF-1alpha availability enables a transcriptional program required for NE prostate tumor development and NE phenotype in PCa.
authors.affiliation: Signal Transduction Program, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.
authors.forename: Jianfei
authors.initials: J
authors.lastname: Qi
authors.forename: Koh
authors.initials: K
authors.lastname: Nakayama
authors.forename: Robert D
authors.initials: RD
authors.lastname: Cardiff
authors.forename: Alexander D
authors.initials: AD
authors.lastname: Borowsky
authors.forename: Karen
authors.initials: K
authors.lastname: Kaul
authors.forename: Roy
authors.initials: R
authors.lastname: Williams
authors.forename: Stan
authors.initials: S
authors.lastname: Krajewski
authors.forename: Dan
authors.initials: D
authors.lastname: Mercola
authors.forename: Philip M
authors.initials: PM
authors.lastname: Carpenter
authors.forename: David
authors.initials: D
authors.lastname: Bowtell
authors.forename: Ze'ev A
authors.initials: ZA
authors.lastname: Ronai
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D000818:Animals; D045744:Cell Line, Tumor; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D051542:Hepatocyte Nuclear Factor 3-beta / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism*; D008114:Liver Neoplasms, Experimental / Q000235:genetics / Q000378:metabolism / Q000556:secondary; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism / Q000556:secondary; D008207:Lymphatic Metastasis; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D018358:Neuroendocrine Tumors / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D009490:Neurosecretory Systems / Q000378:metabolism / Q000473:pathology*; D010641:Phenotype; D011467:Prostate / Q000378:metabolism / Q000473:pathology; D011471:Prostatic Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D015398:Signal Transduction; D015533:Transcriptional Activation; D044767:Ubiquitin-Protein Ligases / Q000502:physiology*
chemical_list: C496503:Foxa2 protein, mouse; C497443:Hif1a protein, mouse; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D051542:Hepatocyte Nuclear Factor 3-beta; C533102:Siah2 protein, mouse; D044767:Ubiquitin-Protein Ligases